(Q38241677)

31 August 2017

title

Calcineurin inhibitors and hypertension: a role for pharmacogenetics? (English)

1 reference

31 August 2017

5

Teun van Gelder

1 reference

31 August 2017

Arthur D Moes

1

1 reference

31 August 2017

Dennis A Hesselink

2

1 reference

31 August 2017

Robert Zietse

3

1 reference

31 August 2017

Ron H N van Schaik

4

1 reference

31 August 2017

Ewout J Hoorn

6

1 reference

31 August 2017

language of work or name

1 reference

1 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

15

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

1243-1251

1 reference

OPTN/SRTR 2011 Annual Data Report: kidney

31 August 2017

cites work

1 reference

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

21 January 2018

1 reference

Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).

21 January 2018

1 reference

Improved long-term outcomes after renal transplantation associated with blood pressure control

21 January 2018

1 reference

Hypertension after kidney transplantation

21 January 2018

1 reference

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.

21 January 2018

1 reference

Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts

21 January 2018

1 reference

Pathogenesis of calcineurin inhibitor-induced hypertension

21 January 2018

1 reference

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.

21 January 2018

1 reference

Mechanisms of FK 506-induced hypertension in the rat.

21 January 2018

1 reference

Vascular mechanisms of cyclosporin-induced hypertension in the rat

21 January 2018

1 reference

The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension

21 January 2018

1 reference

Familial hyperkalemic hypertension

21 January 2018

1 reference

Human hypertension caused by mutations in WNK kinases

21 January 2018

1 reference

WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion

21 January 2018

1 reference

The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation

21 January 2018

1 reference

The WNK kinase network regulating sodium, potassium, and blood pressure

21 January 2018

1 reference

A SPAK isoform switch modulates renal salt transport and blood pressure

21 January 2018

1 reference

Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension

21 January 2018

1 reference

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

21 January 2018

1 reference

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

21 January 2018

1 reference

Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.

21 January 2018

1 reference

Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus.

21 January 2018

1 reference

CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.

21 January 2018

1 reference

Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus

21 January 2018

1 reference

In vitro metabolism of cyclosporine A by human kidney CYP3A5.

21 January 2018

1 reference

A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.

21 January 2018

1 reference

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

21 January 2018

1 reference

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

21 January 2018

1 reference

CYP3A5 and ABCB1 genes and hypertension

21 January 2018

1 reference

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

Sodium and potassium in the pathogenesis of hypertension

21 January 2018

1 reference

Renal corticosterone 6 beta-hydroxylase in the spontaneously hypertensive rat.

21 January 2018

1 reference

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults

21 January 2018

1 reference

CYP3A variation and the evolution of salt-sensitivity variants

21 January 2018

1 reference

Association between the CYP3A5 genotype and blood pressure

21 January 2018

1 reference

Association of CYP3A5 genotypes with blood pressure and renal function in African families

21 January 2018

1 reference

CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study

21 January 2018

1 reference

CYP3A5 genotype is associated with elevated blood pressure

21 January 2018

1 reference

The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population.

21 January 2018

1 reference

Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil

21 January 2018

1 reference

CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men.

21 January 2018

1 reference

P-glycoprotein modulates aldosterone plasma disposition and tissue uptake

21 January 2018

1 reference

Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.

21 January 2018

1 reference

CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt

21 January 2018

1 reference

A functional common polymorphism of the ABCB1 gene is associated with chronic kidney disease and hypertension in Chinese.

21 January 2018

1 reference

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients

21 January 2018

1 reference

The renal WNK kinase pathway: a new link to hypertension.

21 January 2018

1 reference

From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.

21 January 2018

1 reference

Genetic variants of WNK4 in whites and African Americans with hypertension

21 January 2018

1 reference

Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney

21 January 2018

1 reference

Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway

21 January 2018

1 reference

Polymorphisms in the serum- and glucocorticoid-inducible kinase 1 gene are associated with blood pressure and renin response to dietary salt intake.

21 January 2018

1 reference

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells

21 January 2018

1 reference

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients

21 January 2018

1 reference

Hypertension after kidney transplantation: a pathophysiologic approach

21 January 2018

1 reference

Pathogenesis and management of hypertension after kidney transplantation

21 January 2018

1 reference

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial

21 January 2018

1 reference

Angiotensin II blockade in kidney transplant recipients

21 January 2018

1 reference

Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?

21 January 2018

1 reference

No association of theCYP3A5*1allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.14.87

1 reference

31 August 2017

1 reference